TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.31, sa.10, ss.681-687, 2020 (SCI-Expanded)
Background/Aims: Specific serum markers reflecting hepatic inflammation and fibrosis are required to tailor the treatment strategies in non-alcoholic steatohepatitis (NASH). We aimed to investigate the roles of myeloperoxidase (MPO) and calprotectin in predicting the hepatic inflammation status and disease severity in NASH.